Yahoo Finance

Aqualung Therapeutics Corp. Announces FDA Clearance of Investigational New Drug (IND) Application for ALT-100, a Novel mAb Therapy for the Treatment of Acute Respiratory ...

- ALT-100 is the first humanized mAb therapy that targets the eNAMPT protein which plays a pivotal role in regulating inflammation and fibrosis TUCSON, AZ / ACCESSWIRE / September 26, 2022 / Aqualung ...
Yahoo Finance

Aqualung Therapeutics Receives the AZ-Bio Fast Lane Award and Achieves Key FDA-Related Milestones

TUCSON, AZ / ACCESSWIRE / September 13th, 2022 / Aqualung Therapeutics, an immunotherapeutics biotech company with an anti-inflammatory therapeutic platform for serious unchecked inflammatory ...
Business Wire

Aqualung Launches All New XSCAPE Collection Featuring Eco-Responsible Wetsuit

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Aqualung, the leading global designer and manufacturer of dive and water sports gear, today announced the launch of its all new XSCAPE collection. Featuring ...